Advocates of innovation in digital therapeutics

With their potential to increase patient access, facilitate collection of real-world evidence, and extend the reach of personalized medicine, digital therapeutics are poised for integration into healthcare models and standards of care. At Premier Research, we have the vision and the means to design and execute digital therapeutic development strategies that clear a course to success through even the most intricate and opaque regulatory and commercial backdrops.

We understand that, in this disruptive and rapidly evolving sector, a fit-for-purpose approach — and the agility to adapt to changing conditions — is essential for every digital therapeutic. That’s why we have expanded our capabilities and strategic partnerships to support every step of the development journey, from ideation to post-market education and clinician and patient adoption.

Trailblazing experience in a sector that is redirecting the future of healthcare

In digital therapeutics, rapid development is key. Our nimble team offers end-to-end product development capabilities and discerning insights that illuminate the quickest path to commercialization.

• Unmatched in-house expertise in psychiatric and neurological indications.
• Regulatory insights for positive interactions with the FDA and EMA.
• Reimbursement and go-to-market strategies for your digital therapeutic.
• Focused team experienced in supporting decentralized clinical trial strategies for DTx development.

End-to-end digital therapeutic development expertise.